|
|
|
|
Vol. 53, Issue 5, 801-807, May 1998
-L-2',3'-dideoxy-2',3'-didehydro-5-fluoro-CTP with Human
Immunodeficiency Virus-1 Reverse Transcriptase and Human DNA
Polymerases: Implications for Human Immunodeficiency Virus Drug Design
Department of Pharmacology, Yale University School of Medicine, New
Haven, Connecticut 06510 (M.K., W.P., Y.-C. C.),
Vion
Pharmaceuticals, Inc., New Haven, Connecticut 06511 (X.L., S.-H.
C., I.K., T.D.)
The work reported in this article has evaluated the relative molecular
activity of the 5'-triphosphate of a novel
-L-nucleoside with an unsaturated ribose residue,
-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine (
-L-Fd4CTP), with that of
-L-2',3'-dideoxy-5-fluorocytidine (
-L-FddCTP) and 2',3'-dideoxycytidine (ddCTP), on DNA
strand elongation by human immunodeficiency virus-1 reverse
transcriptase (HIV RT) and human DNA polymerases
(pol
),
(pol
),
(pol
), and
(pol
). The concentrations of
-L-Fd4CTP that inhibited the yield of products by 50%
were 0.20 µM, 1.8 µM, and 4.0 µM for HIV RT, pol
, and pol
, respectively. The
-L-Fd4CTP at a concentration as high as 40 µM had no inhibitory effect on pol
, but could inhibit
pol
by 10-20% at 20 µM. The
Km and relative
Vmax values of
-L-Fd4CTP,
-L-FddCTP, and ddCTP for incorporation into the standing start point of
5'-[32P]-oligonucleotide primer annealed with M13mp19
phage DNA by HIV RT and human DNA polymerases were evaluated. The
efficiency of incorporation
(Vmax/Km)
of
-L-Fd4CTP by HIV RT was about 4-fold and 12-fold
higher than that of ddCTP and
-L-FddCTP,
respectively. In contrast, the
Vmax/Km
ratio of
-L-Fd4CTP for pol
was 7-fold lower
than that of ddCTP, but 4-fold higher than that of
-L-FddCTP. Pol
could use
-L-Fd4CTP as a substrate, but only at a high
concentration (>20 µM). Incorporation of
-L-Fd4CTP by pol
could not be detected. A
hypothesis about the preferable recognition of the
2',3'-dideoxy-2',3'-didehydro- structure of
-L-Fd4CTP to that of the 2',3'-dideoxy-structure of
-L-FddCTP by HIV RT is discussed.
This article has been cited by other articles:
![]() |
M. S. Janes, B. J. Hanson, D. M. Hill, G. M. Buller, J. Y. Agnew, S. W. Sherwood, W. G. Cox, K. Yamagata, and R. A. Capaldi Rapid Analysis of Mitochondrial DNA Depletion by Fluorescence In Situ Hybridization and Immunocytochemistry: Potential Strategies for HIV Therapeutic Monitoring J. Histochem. Cytochem., August 1, 2004; 52(8): 1011 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. V. Sosunov, F. Santamaria, L. S. Victorova, G. Gosselin, B. Rayner, and A. A. Krayevsky Stereochemical control of DNA biosynthesis Nucleic Acids Res., March 1, 2000; 28(5): 1170 - 1175. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Le Guerhier, C. Pichoud, S. Guerret, M. Chevallier, C. Jamard, O. Hantz, X.-Y. Li, S.-H. Chen, I. King, C. Trépo, et al. Characterization of the Antiviral Effect of 2',3'-Dideoxy-2', 3'-Didehydro-beta -L-5-Fluorocytidine in the Duck Hepatitis B Virus Infection Model Antimicrob. Agents Chemother., January 1, 2000; 44(1): 111 - 122. [Abstract] [Full Text] |
||||